Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Bradley Allen Maron, M.D.

Title
Institution
Department
Address
Phone
Fax

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R21HL145420 (MARON, BRADLEY) Feb 1, 2019 - Jan 31, 2021
    NIH/NHLBI
    Network medicine, risk stratification, and pulmonary hypertension
    Role: Principal Investigator
  2. R01HL139613 (MARON, BRADLEY) Jan 1, 2018 - Dec 31, 2021
    NIH/NHLBI
    Systems biology, endothelial regulation of fibrosis, and pulmonary vascular disease
    Role: Principal Investigator
  3. R56HL131787 (MARON, BRADLEY) Sep 15, 2017 - Aug 31, 2018
    NIH/NHLBI
    Fibrosome regulation by aldosterone in pulmonary vascular disease
    Role: Principal Investigator
  4. K08HL111207 (MARON, BRADLEY) Feb 1, 2013 - Jan 31, 2018
    NIH/NHLBI
    Aldosterone impairs endothelin B-dependent synthesis of nitric oxide to promote p
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Maron BA, Choudhary G, Tedford RJ, Brittain E. Correspondence on the debate regarding the haemodynamic definition of pulmonary hypertension. Eur Respir J. 2019 Jun; 53(6). PMID: 31167886.
    Citations:    
  2. Maron BA, Wertheim BM. Toward Early Diagnosis of Pulmonary Hypertension: Lessons From Oz. J Am Coll Cardiol. 2019 Jun 04; 73(21):2673-2675. PMID: 31146811.
    Citations:    
  3. Maron BA. Back to the Future: Building Up the Case for Exploring Red Blood Cell Morphology in Pulmonary Arterial Hypertension. Ann Am Thorac Soc. 2019 May; 16(5):548-550. PMID: 31042093.
    Citations:    
  4. Simon MA, Maron BA. Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction Patients: Where to Draw the Line. Am J Respir Crit Care Med. 2019 Apr 30. PMID: 31038986.
    Citations:    
  5. Gillmeyer KR, Lee KM, Shao Q, Miller DR, Maron BA, Klings ES, Rinne ST, Wiener RS. Multisystem Healthcare Use among U.S. Veterans with Pulmonary Hypertension. Ann Am Thorac Soc. 2019 Apr 26. PMID: 31026406.
    Citations:    
  6. Maron BJ, Maron MS, Maron BA, Loscalzo J. Moving Beyond the Sarcomere to Explain Heterogeneity in Hypertrophic Cardiomyopathy: JACC Review Topic of the Week. J Am Coll Cardiol. 2019 Apr 23; 73(15):1978-1986. PMID: 31000001.
    Citations:    
  7. Maron BA, Ryan JJ. A Concerning Trend for Patients With Pulmonary Hypertension in the Era of Evidence-Based Medicine. Circulation. 2019 Apr 16; 139(16):1861-1864. PMID: 30986105.
    Citations:    
  8. Leopold JA, Maron BA. Precision Medicine in Pulmonary Arterial Hypertension. Circ Res. 2019 Mar 15; 124(6):832-833. PMID: 30870130.
    Citations:    
  9. Wertheim BM, Lin YD, Zhang YY, Samokhin AO, Alba GA, Arons E, Yu PB, Maron BA. Isolating pulmonary microvascular endothelial cells ex vivo: Implications for pulmonary arterial hypertension, and a caution on the use of commercial biomaterials. PLoS One. 2019; 14(2):e0211909. PMID: 30811450.
    Citations:    
  10. Maron BA, Wilkins MR. TORward a Molecular Convergence Point in Pulmonary Arterial Hypertension With mTOR. JACC Basic Transl Sci. 2018 Dec; 3(6):763-765. PMID: 30623135.
    Citations:    
  11. Musri MM, Coll-Bonfill N, Maron BA, Peinado VI, Wang RS, Altirriba J, Blanco I, Oldham WM, Tura-Ceide O, García-Lucio J, de la Cruz-Thea B, Meister G, Loscalzo J, Barberà JA. MicroRNA Dysregulation in Pulmonary Arteries from Chronic Obstructive Pulmonary Disease. Relationships with Vascular Remodeling. Am J Respir Cell Mol Biol. 2018 10; 59(4):490-499. PMID: 29757677.
    Citations:    Fields:    
  12. Kolte D, Lakshmanan S, Jankowich MD, Brittain EL, Maron BA, Choudhary G. Mild Pulmonary Hypertension Is Associated With Increased Mortality: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2018 Sep 18; 7(18):e009729. PMID: 30371195.
    Citations: 1     Fields:    
  13. Agarwal MA, Shah M, Patel B, Nolan VG, Reed GL, Oudiz RJ, Choudhary G, Maron BA. Association between Pulmonary Hypertension and Clinical Outcomes in Hospitalized Patients with Sickle Cell Disease. Am J Respir Crit Care Med. 2018 Aug 15; 198(4):534-537. PMID: 29648884.
    Citations:    Fields:    
  14. Leary PJ, Kolb TM, Maron BA, Tedford RJ, Zamanian RT. Reply: Can treprostinil-induced early gastrointestinal side effects serve as predictors of pulmonary arterial hypertension prognosis? Int J Cardiol. 2018 08 01; 264:188. PMID: 29776569.
    Citations:    Fields:    Translation:Humans
  15. Abman SH, Lovering AT, Maron BA. Pulmonary Vascular Disease Across the Life Span: A Call for Bridging Pediatric and Adult Cardiopulmonary Research and Care. Am J Respir Crit Care Med. 2018 Jul 18. PMID: 30020807.
    Citations:    Fields:    
  16. Brittain EL, Thennapan T, Maron BA, Chan SY, Austin ED, Spiekerkoetter E, Bogaard HJ, Guignabert C, Paulin R, Machado RF, Yu PB. Update in Pulmonary Vascular Disease 2016 and 2017. Am J Respir Crit Care Med. 2018 Jul 01; 198(1):13-23. PMID: 29533671.
    Citations:    Fields:    
  17. Leary PJ, Hess E, Barón AE, Branch KR, Choudhary G, Hough CL, Maron BA, Ralph DD, Ryan JJ, Tedford RJ, Weiss NS, Zamanian RT, Lahm T. H2 Receptor Antagonist Use and Mortality in Pulmonary Hypertension: Insight from the VA-CART Program. Am J Respir Crit Care Med. 2018 Jun 15; 197(12):1638-1641. PMID: 29437490.
    Citations:    Fields:    
  18. Samokhin AO, Stephens T, Wertheim BM, Wang RS, Vargas SO, Yung LM, Cao M, Brown M, Arons E, Dieffenbach PB, Fewell JG, Matar M, Bowman FP, Haley KJ, Alba GA, Marino SM, Kumar R, Rosas IO, Waxman AB, Oldham WM, Khanna D, Graham BB, Seo S, Gladyshev VN, Yu PB, Fredenburgh LE, Loscalzo J, Leopold JA, Maron BA. NEDD9 targets COL3A1 to promote endothelial fibrosis and pulmonary arterial hypertension. Sci Transl Med. 2018 Jun 13; 10(445). PMID: 29899023.
    Citations:    
  19. Leary PJ, Maron BA, Tedford RJ, Lahm T. Pulmonary Hypertension: Good Intentions, But a Questionable Approach. Ann Am Thorac Soc. 2018 Jun; 15(6):664-666. PMID: 29856254.
    Citations:    Fields:    
  20. Agarwal S, Spiekerkoetter E, Austin ED, de Jesus Perez V, Dezfulian C, Maron BA, Ryan JJ, Starks MA, Yu PB, Bonnet S, Perman SM. Career Development of Young Physician-Scientists in the Cardiovascular Sciences: Perspective and Advice From the Early Career Committee of the Cardiopulmonary, Critical Care, and Resuscitation Council of the American Heart Association. Circ Res. 2018 May 11; 122(10):1330-1333. PMID: 29748361.
    Citations:    Fields:    
  21. Carroll BJ, Steigner ML, Priya S, Bhatt DL, Maron BA. Segmental Arterial Mediolysis: An Important but Often Overlooked Cause of Multi-Vessel Thrombosis. Am J Med. 2018 Jun; 131(6):e231-e234. PMID: 29505754.
    Citations:    Fields:    
  22. Maron BA, Wertheim BM, Gladwin MT. Under Pressure to Clarify Pulmonary Hypertension Clinical Risk. Am J Respir Crit Care Med. 2018 Feb 15; 197(4):423-426. PMID: 29216444.
    Citations:    Fields:    
  23. Oldham WM, Oliveira RKF, Wang RS, Opotowsky AR, Rubins DM, Hainer J, Wertheim BM, Alba GA, Choudhary G, Tornyos A, MacRae CA, Loscalzo J, Leopold JA, Waxman AB, Olschewski H, Kovacs G, Systrom DM, Maron BA. Network Analysis to Risk Stratify Patients With Exercise Intolerance. Circ Res. 2018 Mar 16; 122(6):864-876. PMID: 29437835.
    Citations:    Fields:    
  24. Wang RS, Oldham WM, Maron BA, Loscalzo J. Systems Biology Approaches to Redox Metabolism in Stress and Disease States. Antioxid Redox Signal. 2018 Oct 01; 29(10):953-972. PMID: 29121773.
    Citations:    Fields:    
  25. Maron BA, Brittain EL, Choudhary G, Gladwin MT. Redefining pulmonary hypertension. Lancet Respir Med. 2018 03; 6(3):168-170. PMID: 29269004.
    Citations: 4     Fields:    Translation:Humans
  26. Assad TR, Maron BA, Robbins IM, Xu M, Huang S, Harrell FE, Farber-Eger EH, Wells QS, Choudhary G, Hemnes AR, Brittain EL. Prognostic Effect and Longitudinal Hemodynamic Assessment of Borderline Pulmonary Hypertension. JAMA Cardiol. 2017 12 01; 2(12):1361-1368. PMID: 29071338.
    Citations: 3     Fields:    
  27. Ventetuolo CE, Hess E, Austin ED, Barón AE, Klinger JR, Lahm T, Maddox TM, Plomondon ME, Thompson L, Zamanian RT, Choudhary G, Maron BA. Sex-based differences in veterans with pulmonary hypertension: Results from the veterans affairs-clinical assessment reporting and tracking database. PLoS One. 2017; 12(11):e0187734. PMID: 29121097.
    Citations:    Fields:    Translation:Humans
  28. Hemnes AR, Beck GJ, Newman JH, Abidov A, Aldred MA, Barnard J, Berman Rosenzweig E, Borlaug BA, Chung WK, Comhair SAA, Erzurum SC, Frantz RP, Gray MP, Grunig G, Hassoun PM, Hill NS, Horn EM, Hu B, Lempel JK, Maron BA, Mathai SC, Olman MA, Rischard FP, Systrom DM, Tang WHW, Waxman AB, Xiao L, Yuan JX, Leopold JA. PVDOMICS: A Multi-Center Study to Improve Understanding of Pulmonary Vascular Disease Through Phenomics. Circ Res. 2017 10 27; 121(10):1136-1139. PMID: 29074534.
    Citations: 6     Fields:    
  29. Opotowsky AR, Hess E, Maron BA, Brittain EL, Barón AE, Maddox TM, Alshawabkeh LI, Wertheim BM, Xu M, Assad TR, Rich JD, Choudhary G, Tedford RJ. Thermodilution vs Estimated Fick Cardiac Output Measurement in Clinical Practice: An Analysis of Mortality From the Veterans Affairs Clinical Assessment, Reporting, and Tracking (VA CART) Program and Vanderbilt University. JAMA Cardiol. 2017 10 01; 2(10):1090-1099. PMID: 28877293.
    Citations: 1     Fields:    
  30. van Riel ACMJ, Systrom DM, Oliveira RKF, Landzberg MJ, Mulder BJM, Bouma BJ, Maron BA, Shah AM, Waxman AB, Opotowsky AR. Hemodynamic and metabolic characteristics associated with development of a right ventricular outflow tract pressure gradient during upright exercise. PLoS One. 2017; 12(6):e0179053. PMID: 28636647.
    Citations:    Fields:    Translation:Humans
  31. Oliveira RKF, Faria-Urbina M, Maron BA, Santos M, Waxman AB, Systrom DM. Functional impact of exercise pulmonary hypertension in patients with borderline resting pulmonary arterial pressure. Pulm Circ. 2017 Jul-Sep; 7(3):654-665. PMID: 28895507.
    Citations: 3     
  32. Leary PJ, Kang S, Kolb TM, Maron BA, Ralph DD, Rao Y, Tedford RJ, Zamanian RT. What's in a side effect? The association between pulmonary vasodilator adverse drug events and clinical outcomes in patients with pulmonary arterial hypertension. Int J Cardiol. 2017 Aug 01; 240:386-391. PMID: 28412029.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  33. Covella M, Rowin EJ, Hill NS, Preston IR, Milan A, Opotowsky AR, Maron BJ, Maron MS, Maron BA. Mechanism of Progressive Heart Failure and Significance of Pulmonary Hypertension in Obstructive Hypertrophic Cardiomyopathy. Circ Heart Fail. 2017 Apr; 10(4):e003689. PMID: 28396501.
    Citations: 2     Fields:    Translation:Humans
  34. Metkus TS, Tampakakis E, Mullin CJ, Houston BA, Kolb TM, Mathai SC, Damico R, Maron BA, Hassoun PM, Brower RG, Tedford RJ. Pulmonary Arterial Compliance in Acute Respiratory Distress Syndrome: Clinical Determinants and Association With Outcome From the Fluid and Catheter Treatment Trial Cohort. Crit Care Med. 2017 03; 45(3):422-429. PMID: 27941369.
    Citations: 4     Fields:    Translation:Humans
  35. van Riel AC, Systrom DM, Oliveira RK, Landzberg MJ, Mulder BJ, Bouma BJ, Maron BA, Shah AM, Waxman AB, Opotowsky AR. Development of a Right Ventricular Outflow Tract Gradient During Upright Exercise: A Hemodynamic Observation. J Am Coll Cardiol. 2017 02 07; 69(5):595-597. PMID: 28153114.
    Citations: 1     Fields:    
  36. Maron BA, Abman SH. Translational Advances in the Field of Pulmonary Hypertension. Focusing on Developmental Origins and Disease Inception for the Prevention of Pulmonary Hypertension. Am J Respir Crit Care Med. 2017 02 01; 195(3):292-301. PMID: 27854133.
    Citations: 7     Fields:    Translation:Humans
  37. Maron BA, Machado RF, Shimoda L. Pulmonary vascular and ventricular dysfunction in the susceptible patient (2015 Grover Conference series). Pulm Circ. 2016 Dec; 6(4):426-438. PMID: 28090285.
    Citations: 2     
  38. Maron BA, Ryan JJ. Treatment differences in pulmonary arterial hypertension management. Pulm Circ. 2016 Dec; 6(4):619. PMID: 28090308.
    Citations: 2     
  39. Maron BA, Galiè N. Diagnosis, Treatment, and Clinical Management of Pulmonary Arterial Hypertension in the Contemporary Era: A Review. JAMA Cardiol. 2016 Dec 01; 1(9):1056-1065. PMID: 27851839.
    Citations: 2     Fields:    
  40. Maron BA, Leopold JA. Systems biology: An emerging strategy for discovering novel pathogenetic mechanisms that promote cardiovascular disease. Glob Cardiol Sci Pract. 2016 Sep 30; 2016(3):e201627. PMID: 29043273.
    Citations: 1     
  41. Manrai AK, Funke BH, Rehm HL, Olesen MS, Maron BA, Szolovits P, Margulies DM, Loscalzo J, Kohane IS. Genetic Misdiagnoses and the Potential for Health Disparities. N Engl J Med. 2016 Aug 18; 375(7):655-65. PMID: 27532831.
    Citations: 68     Fields:    Translation:Humans
  42. Maron BJ, Maron BA. Revisiting Athlete's Heart Versus Pathologic Hypertrophy: ARVC and the Right Ventricle. JACC Cardiovasc Imaging. 2017 04; 10(4):394-397. PMID: 27544897.
    Citations: 1     Fields:    Translation:Humans
  43. Maron BA, Gladwin MT, Simon MA. Update in Pulmonary Vascular Disease 2015. Am J Respir Crit Care Med. 2016 06 15; 193(12):1337-44. PMID: 27304242.
    Citations: 2     Fields:    Translation:Humans
  44. Leopold JA, Maron BA. Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension. Int J Mol Sci. 2016 May 18; 17(5). PMID: 27213345.
    Citations: 8     Fields:    Translation:HumansCells
  45. Maron BA. Independence Day: Separating Right Ventricular Function From Pulmonary Arterial Hypertension in Systemic Sclerosis. Circulation. 2016 Jun 14; 133(24):2345-7. PMID: 27169738.
    Citations: 1     Fields:    Translation:Humans
  46. Aguero J, Ishikawa K, Hadri L, Santos-Gallego CG, Fish KM, Kohlbrenner E, Hammoudi N, Kho C, Lee A, Ibáñez B, García-Alvarez A, Zsebo K, Maron BA, Plataki M, Fuster V, Leopold JA, Hajjar RJ. Intratracheal Gene Delivery of SERCA2a Ameliorates Chronic Post-Capillary Pulmonary Hypertension: A Large Animal Model. J Am Coll Cardiol. 2016 05 03; 67(17):2032-46. PMID: 27126531.
    Citations: 8     Fields:    Translation:AnimalsCells
  47. Zonfrillo MR, Janigian NG, Maron BA. Death or Severe Injury at the Ball Game. Curr Sports Med Rep. 2016 May-Jun; 15(3):132-3. PMID: 27172075.
    Citations:    Fields:    Translation:Humans
  48. Aghamohammadzadeh R, Zhang YY, Stephens TE, Arons E, Zaman P, Polach KJ, Matar M, Yung LM, Yu PB, Bowman FP, Opotowsky AR, Waxman AB, Loscalzo J, Leopold JA, Maron BA. Up-regulation of the mammalian target of rapamycin complex 1 subunit Raptor by aldosterone induces abnormal pulmonary artery smooth muscle cell survival patterns to promote pulmonary arterial hypertension. FASEB J. 2016 07; 30(7):2511-27. PMID: 27006450.
    Citations: 5     Fields:    Translation:HumansAnimalsCells
  49. Kalra A, Harris KM, Maron BA, Maron MS, Garberich RF, Haas TS, Lesser JR, Maron BJ. Relation of Doppler Tissue Imaging Parameters With Heart Failure Progression in Hypertrophic Cardiomyopathy. Am J Cardiol. 2016 06 01; 117(11):1808-14. PMID: 27089980.
    Citations:    Fields:    Translation:Humans
  50. Maron BA. The quest for biomarker discovery in pulmonary arterial hypertension: the right takes lessons from the left. Heart. 2016 Mar; 102(5):335-6. PMID: 26869633.
    Citations:    Fields:    Translation:Humans
  51. Maron BA, Hess E, Maddox TM, Opotowsky AR, Tedford RJ, Lahm T, Joynt KE, Kass DJ, Stephens T, Stanislawski MA, Swenson ER, Goldstein RH, Leopold JA, Zamanian RT, Elwing JM, Plomondon ME, Grunwald GK, Barón AE, Rumsfeld JS, Choudhary G. Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. Circulation. 2016 Mar 29; 133(13):1240-8. PMID: 26873944.
    Citations: 29     Fields:    Translation:Humans
  52. Berry NC, Manyoo A, Oldham WM, Stephens TE, Goldstein RH, Waxman AB, Tracy JA, Leary PJ, Leopold JA, Kinlay S, Opotowsky AR, Systrom DM, Maron BA. Protocol for exercise hemodynamic assessment: performing an invasive cardiopulmonary exercise test in clinical practice. Pulm Circ. 2015 Dec; 5(4):610-8. PMID: 26697168.
    Citations: 6     
  53. Maron BA, Stephens TE, Farrell LA, Oldham WM, Loscalzo J, Leopold JA, Lewis GD. Elevated pulmonary arterial and systemic plasma aldosterone levels associate with impaired cardiac reserve capacity during exercise in left ventricular systolic heart failure patients: A pilot study. J Heart Lung Transplant. 2016 Mar; 35(3):342-351. PMID: 26586488.
    Citations: 4     Fields:    Translation:Humans
  54. Maron BA, Leopold JA. Emerging Concepts in the Molecular Basis of Pulmonary Arterial Hypertension: Part II: Neurohormonal Signaling Contributes to the Pulmonary Vascular and Right Ventricular Pathophenotype of Pulmonary Arterial Hypertension. Circulation. 2015 Jun 09; 131(23):2079-91. PMID: 26056345.
    Citations: 14     Fields:    Translation:HumansCells
  55. Wang RS, Maron BA, Loscalzo J. Systems medicine: evolution of systems biology from bench to bedside. Wiley Interdiscip Rev Syst Biol Med. 2015 Jul-Aug; 7(4):141-61. PMID: 25891169.
    Citations: 17     Fields:    Translation:Humans
  56. Steiner J, Wu WC, Jankowich M, Maron BA, Sharma S, Choudhary G. Echocardiographic predictors of mortality in patients with pulmonary hypertension and cardiopulmonary comorbidities. PLoS One. 2015; 10(3):e0119277. PMID: 25774911.
    Citations: 5     Fields:    Translation:Humans
  57. Ryan JJ, Rich JD, Maron BA. Building the case for novel clinical trials in pulmonary arterial hypertension. Circ Cardiovasc Qual Outcomes. 2015 Jan; 8(1):114-23. PMID: 25604559.
    Citations: 4     Fields:    Translation:Humans
  58. Dudzinski DM, Bhatt DL, Aragam JR, Maron BA. Explaining unexplained dyspnea: the ever "holesome" heart. Circulation. 2014 Dec 02; 130(23):2057-66. PMID: 25446059.
    Citations: 2     Fields:    Translation:Humans
  59. Maron BA. Emerging hemodynamic signatures of the right heart (Third International Right Heart Failure Summit, part 2). Pulm Circ. 2014 Dec; 4(4):705-16. PMID: 25610606.
    Citations: 1     
  60. Leopold JA, Maron BA. New thematic series: recent advances in pulmonary hypertension. Circulation. 2014 Nov 11; 130(20):1771. PMID: 25385935.
    Citations:    
  61. Maron BA. Hemodynamics should be the primary approach to diagnosing, following, and managing pulmonary arterial hypertension. Can J Cardiol. 2015 Apr; 31(4):515-20. PMID: 25742869.
    Citations: 2     Fields:    Translation:Humans
  62. Ryan JJ, Butrous G, Maron BA. The heterogeneity of clinical practice patterns among an international cohort of pulmonary arterial hypertension experts. Pulm Circ. 2014 Sep; 4(3):441-51. PMID: 25621157.
    Citations: 12     
  63. Maron BA, Leopold JA. The role of the renin-angiotensin-aldosterone system in the pathobiology of pulmonary arterial hypertension (2013 Grover Conference series). Pulm Circ. 2014 Jun; 4(2):200-10. PMID: 25006439.
    Citations: 12     
  64. Nayor M, Maron BA. Contemporary approach to paradoxical embolism. Circulation. 2014 May 06; 129(18):1892-7. PMID: 24799505.
    Citations: 3     Fields:    Translation:Humans
  65. Maron BA, Oldham WM, Chan SY, Vargas SO, Arons E, Zhang YY, Loscalzo J, Leopold JA. Upregulation of steroidogenic acute regulatory protein by hypoxia stimulates aldosterone synthesis in pulmonary artery endothelial cells to promote pulmonary vascular fibrosis. Circulation. 2014 Jul 08; 130(2):168-79. PMID: 25001622.
    Citations: 14     Fields:    Translation:HumansAnimalsCells
  66. Maron BA, Goldstein RH, Rounds SI, Shapiro S, Jankowich M, Garshick E, Moy ML, Gagnon D, Choudhary G. Study design and rationale for investigating phosphodiesterase type 5 inhibition for the treatment of pulmonary hypertension due to chronic obstructive lung disease: the TADA-PHiLD (TADAlafil for Pulmonary Hypertension associated with chronic obstructive Lung Disease) trial. Pulm Circ. 2013 Dec; 3(4):889-97. PMID: 25006405.
    Citations: 2     
  67. Opotowsky AR, Santos M, Maron BA, Afilalo J, Waxman AB, Landzberg MJ, Forfia PR. Towards widespread noninvasive assessment of pulmonary vascular resistance in clinical practice. J Am Soc Echocardiogr. 2014 Jan; 27(1):108-9. PMID: 24280251.
    Citations: 1     Fields:    Translation:Humans
  68. Yin T, Bader AR, Hou TK, Maron BA, Kao DD, Qian R, Kohane DS, Handy DE, Loscalzo J, Zhang YY. SDF-1a in glycan nanoparticles exhibits full activity and reduces pulmonary hypertension in rats. Biomacromolecules. 2013 Nov 11; 14(11):4009-20. PMID: 24059347.
    Citations: 2     Fields:    Translation:HumansAnimalsCells
  69. Maron BA, Choudhary G, Khan UA, Jankowich MD, McChesney H, Ferrazzani SJ, Gaddam S, Sharma S, Opotowsky AR, Bhatt DL, Rocco TP, Aragam JR. Clinical profile and underdiagnosis of pulmonary hypertension in US veteran patients. Circ Heart Fail. 2013 Sep 01; 6(5):906-12. PMID: 23811965.
    Citations: 13     Fields:    Translation:Humans
  70. Hadri L, Kratlian RG, Benard L, Maron BA, Dorfmüller P, Ladage D, Guignabert C, Ishikawa K, Aguero J, Ibanez B, Turnbull IC, Kohlbrenner E, Liang L, Zsebo K, Humbert M, Hulot JS, Kawase Y, Hajjar RJ, Leopold JA. Therapeutic efficacy of AAV1.SERCA2a in monocrotaline-induced pulmonary arterial hypertension. Circulation. 2013 Jul 30; 128(5):512-23. PMID: 23804254.
    Citations: 24     Fields:    Translation:HumansAnimalsCells
  71. Maron BA, Waxman AB, Opotowsky AR, Gillies H, Blair C, Aghamohammadzadeh R, Loscalzo J, Leopold JA. Effectiveness of spironolactone plus ambrisentan for treatment of pulmonary arterial hypertension (from the [ARIES] study 1 and 2 trials). Am J Cardiol. 2013 Sep 01; 112(5):720-5. PMID: 23751938.
    Citations: 15     Fields:    Translation:HumansCTClinical Trials
  72. Opotowsky AR, Clair M, Afilalo J, Landzberg MJ, Waxman AB, Moko L, Maron BA, Vaidya A, Forfia PR. A simple echocardiographic method to estimate pulmonary vascular resistance. Am J Cardiol. 2013 Sep 15; 112(6):873-82. PMID: 23735649.
    Citations: 10     Fields:    Translation:Humans
  73. Maron BA, Cockrill BA, Waxman AB, Systrom DM. The invasive cardiopulmonary exercise test. Circulation. 2013 Mar 12; 127(10):1157-64. PMID: 23479667.
    Citations: 14     Fields:    Translation:Humans
  74. Clarke JC, Aragam JR, Bhatt DL, Brown JD, Ferrazzani S, Pietro DA, Maron BA. An unusual cause of dyspnea diagnosed late in life: severe pulmonary hypertension resulting from isolated anomalous pulmonary venous connection. Circ Cardiovasc Imaging. 2013 Mar 01; 6(2):349-51. PMID: 23512781.
    Citations: 1     Fields:    Translation:Humans
  75. Maron BA, Loscalzo J. Pulmonary hypertension: pathophysiology and signaling pathways. Handb Exp Pharmacol. 2013; 218:31-58. PMID: 24092335.
    Citations: 7     Fields:    Translation:HumansAnimalsCells
  76. Maron BA. Targeting neurohumoral signaling to treat pulmonary hypertension: the right ventricle coming into focus. Circulation. 2012 Dec 11; 126(24):2806-8. PMID: 23124028.
    Citations: 2     Fields:    Translation:HumansAnimals
  77. Maron BA, Opotowsky AR, Landzberg MJ, Loscalzo J, Waxman AB, Leopold JA. Plasma aldosterone levels are elevated in patients with pulmonary arterial hypertension in the absence of left ventricular heart failure: a pilot study. Eur J Heart Fail. 2013 Mar; 15(3):277-83. PMID: 23111998.
    Citations: 20     Fields:    Translation:Humans
  78. Maron BA, Michel T. Subcellular localization of oxidants and redox modulation of endothelial nitric oxide synthase. Circ J. 2012; 76(11):2497-512. PMID: 23075817.
    Citations: 11     Fields:    Translation:HumansAnimalsCells
  79. Maron BA, Tang SS, Loscalzo J. S-nitrosothiols and the S-nitrosoproteome of the cardiovascular system. Antioxid Redox Signal. 2013 Jan 20; 18(3):270-87. PMID: 22770551.
    Citations: 20     Fields:    Translation:HumansAnimalsCells
  80. Maron BA, Zhang YY, White K, Chan SY, Handy DE, Mahoney CE, Loscalzo J, Leopold JA. Aldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension. Circulation. 2012 Aug 21; 126(8):963-74. PMID: 22787113.
    Citations: 41     Fields:    Translation:HumansAnimalsCells
  81. Maron BA, Bhatt DL, Nykiel M, Kinlay S, Waxman AB. Protocol for vasoreactivity testing with epoprostenol in pulmonary hypertension. Crit Pathw Cardiol. 2012 Mar; 11(1):40-2. PMID: 22337220.
    Citations: 2     Fields:    Translation:Humans
  82. Parikh VN, Jin RC, Rabello S, Gulbahce N, White K, Hale A, Cottrill KA, Shaik RS, Waxman AB, Zhang YY, Maron BA, Hartner JC, Fujiwara Y, Orkin SH, Haley KJ, Barabási AL, Loscalzo J, Chan SY. MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach. Circulation. 2012 Mar 27; 125(12):1520-32. PMID: 22371328.
    Citations: 91     Fields:    Translation:HumansAnimalsCells
  83. Maron BJ, Maron MS, Maron BA, Haas TS, Altman RK, Smalley SJ, Doerer JJ, Link MS, Mooney MR. Successful therapeutic hypothermia in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2011 Jun 14; 57(24):2454-6. PMID: 21640539.
    Citations:    Fields:    Translation:Humans
  84. Maron BA, Shekar PS, Goldhaber SZ. Paradoxical embolism. Circulation. 2010 Nov 09; 122(19):1968-72. PMID: 21060086.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  85. Maron BA, Leopold JA. Aldosterone receptor antagonists: effective but often forgotten. Circulation. 2010 Feb 23; 121(7):934-9. PMID: 20177008.
    Citations: 17     Fields:    Translation:Humans
  86. Maron BA, Goldhaber SZ, Sturzu AC, Rhee DK, Ali BS, Shah PB, Kirshenbaum JM. Catheter-directed thrombolysis for giant right atrial thrombus. Circ Cardiovasc Imaging. 2010 Jan; 3(1):126-7. PMID: 20086226.
    Citations:    Fields:    Translation:Humans
  87. Maron BA, Kolandaivelu K, Rhee DK, Bukhman AK, Edelman ER. Echocardiographic capture of right ventricular wall rupture during inferior wall acute myocardial infarction. Am J Cardiol. 2009 May 15; 103(10):1478-80. PMID: 19427450.
    Citations:    Fields:    Translation:Humans
  88. Maron BA, Zhang YY, Handy DE, Beuve A, Tang SS, Loscalzo J, Leopold JA. Aldosterone increases oxidant stress to impair guanylyl cyclase activity by cysteinyl thiol oxidation in vascular smooth muscle cells. J Biol Chem. 2009 Mar 20; 284(12):7665-72. PMID: 19141618.
    Citations: 34     Fields:    Translation:AnimalsCells
  89. Maron BA, Loscalzo J. The treatment of hyperhomocysteinemia. Annu Rev Med. 2009; 60:39-54. PMID: 18729731.
    Citations: 54     Fields:    Translation:Humans
  90. Maron BA, Leopold JA. Mineralocorticoid receptor antagonists and endothelial function. Curr Opin Investig Drugs. 2008 Sep; 9(9):963-9. PMID: 18729003.
    Citations: 4     Fields:    Translation:HumansAnimals
  91. Markert RJ, Rodenhauser P, El-Baghdadi MM, Juskaite K, Hillel AT, Maron BA. Personality as a prognostic factor for specialty choice: a prospective study of 4 medical school classes. Medscape J Med. 2008 Feb 27; 10(2):49. PMID: 18382718.
    Citations: 7     Fields:    Translation:Humans
  92. Maron BA, Loscalzo J. Should hyperhomocysteinemia be treated in patients with atherosclerotic disease? Curr Atheroscler Rep. 2007 Nov; 9(5):375-83. PMID: 18001620.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  93. Maron BA, Haas TS, Maron BJ. Sudden death from collapsing sand holes. N Engl J Med. 2007 Jun 21; 356(25):2655-6. PMID: 17582084.
    Citations:    Fields:    Translation:Humans
  94. de la Monte SM, Jhaveri A, Maron BA, Wands JR. Nitric oxide synthase 3-mediated neurodegeneration after intracerebral gene delivery. J Neuropathol Exp Neurol. 2007 Apr; 66(4):272-83. PMID: 17413318.
    Citations: 5     Fields:    Translation:HumansAnimals
  95. Leopold JA, Dam A, Maron BA, Scribner AW, Liao R, Handy DE, Stanton RC, Pitt B, Loscalzo J. Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity. Nat Med. 2007 Feb; 13(2):189-97. PMID: 17273168.
    Citations: 100     Fields:    Translation:HumansCells
  96. Maron BA, Fein S, Maron BJ, Hillel AT, El Baghdadi MM, Rodenhauser P. Ability of prospective assessment of personality profiles to predict the practice specialty of medical students. Proc (Bayl Univ Med Cent). 2007 Jan; 20(1):22-6. PMID: 17256038.
    Citations: 5     
  97. Maron BA, Loscalzo J. Homocysteine. Clin Lab Med. 2006 Sep; 26(3):591-609, vi. PMID: 16938586.
    Citations: 4     Fields:    Translation:HumansAnimals
  98. Maron BA, Dansereau LM, Maron BJ, Easton JD. Impact of postgraduate medical education on recognition of stroke. Cardiol Rev. 2005 Mar-Apr; 13(2):73-5. PMID: 15705256.
    Citations: 1     Fields:    Translation:Humans
  99. Maron BA, Maron BJ. Sudden death and other risks associated with dry-sand beach holes. JAMA. 2001 Apr 18; 285(15):1964. PMID: 11308431.
    Citations:    Fields:    
  100. Schwartz BD, Maron BA, Evans WJ, Winstead DK. Smooth pursuit tracking deficits of patients with schizophrenia at specific within-sine wave bins. Neuropsychiatry Neuropsychol Behav Neurol. 1999 Oct; 12(4):221-9. PMID: 10527106.
    Citations:    Fields:    Translation:Humans
  101. Schwartz BD, Maron BA, Evans WJ, Winstead DK. High velocity transient visual processing deficits diminish ability of patients with schizophrenia to recognize objects. Neuropsychiatry Neuropsychol Behav Neurol. 1999 Jul; 12(3):170-7. PMID: 10456801.
    Citations: 12     Fields:    Translation:Humans
  102. Brosius FC, Schwartz DE, Gleason WL, Maron B, Jones M, Roberts WC. Left atrial-to-right atrial shunt without atrial septal defect or precordial murmur. Pulmonary varix and hypertrophic cardiomyopathy. Chest. 1982 Jan; 81(1):91-4. PMID: 6459214.
    Citations:    Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Maron's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (340)
Explore
_
Co-Authors (60)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.